0001437749-14-000043.txt : 20140102
0001437749-14-000043.hdr.sgml : 20140101
20140102160242
ACCESSION NUMBER: 0001437749-14-000043
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140102
FILED AS OF DATE: 20140102
DATE AS OF CHANGE: 20140102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TearLab Corp
CENTRAL INDEX KEY: 0001299139
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 593434771
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9980 HUENNEKENS ST.
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-794-1400
MAIL ADDRESS:
STREET 1: 9980 HUENNEKENS ST.
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: OccuLogix, Inc.
DATE OF NAME CHANGE: 20040730
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Karpecki Paul
CENTRAL INDEX KEY: 0001487348
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51030
FILM NUMBER: 14501805
MAIL ADDRESS:
STREET 1: 11025 ROSELLE STREET
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
rdgdoc.xml
PRIMARY DOCUMENT
X0306
4
2014-01-02
0001299139
TearLab Corp
TEAR
0001487348
Karpecki Paul
9980 HUENNEKENS ST., STE 100
SAN DIEGO
CA
92121
1
Common Stock
2014-01-02
4
M
0
3376
3.12
A
6876
D
Common Stock
2014-01-02
4
M
0
548
2.59
A
7424
D
Common Stock
2014-01-02
4
M
0
1076
2.11
A
8500
D
Common Stock
2014-01-02
4
S
0
5000
9.4687
D
3500
D
Stock Option (right to buy)
3.12
2014-01-02
4
M
0
3376
0
D
2018-12-12
Common Stock
3376
0
D
Stock Option (right to buy)
2.59
2014-01-02
4
M
0
548
0
D
2020-04-01
Common Stock
548
0
D
Stock Option (right to buy)
2.11
2014-01-02
4
M
0
1076
0
D
2020-07-01
Common Stock
1076
3710
D
The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on April 2, 2013.
Represents the weighted average share price of an aggregate total of 5,000 shares sold in the price range of $9.27 to $9.53 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Twenty-five percent (25%) of the shares subject to the option vested and became exercisable on April 12, 2010, and, thereafter, one thirty sixth (1/36th) of the remaining shares subject to the option vested and became exercisable in equal monthly installments over the next thirty six (36) months.
One hundred percent of the shares subject to the option vested and became exercisable on April 1, 2010.
One hundred percent of the shares subject to the option vested and became exercisable on July 1, 2010.
/s/ William Dumencu, as Attorney-in-Fact
2014-01-02